Feasibility of Low-Dose Interleukin-2 Therapy Following T-Cell-Depleted Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Matched or -Mismatched Family Member Donors.

Saved in:
Bibliographic Details
Title: Feasibility of Low-Dose Interleukin-2 Therapy Following T-Cell-Depleted Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Matched or -Mismatched Family Member Donors.
Authors: Rizzieri, David A.1 (AUTHOR) rizzi003@mc.duke.edu, Crout, Christopher1 (AUTHOR), Storms, Robert1 (AUTHOR), Golob, Jared1 (AUTHOR), Long, Gwynn D.1 (AUTHOR), Gasparetto, Cristina1 (AUTHOR), Sullivan, Keith M.1 (AUTHOR), Horwitz, Mitchell1 (AUTHOR), Chute, John1 (AUTHOR), Lagoo, Anand S.1 (AUTHOR), Morris, Ashley1 (AUTHOR), Beaven, Anne1 (AUTHOR), Yang, Yiping1 (AUTHOR), Peterson, Bercedis1 (AUTHOR), Li, Zhiguo1 (AUTHOR), Chao, Nelson J.1 (AUTHOR)
Source: Cancer Investigation. Jan2011, Vol. 29 Issue 1, p56-61. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:07357907
DOI:10.3109/07357907.2010.535055